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According to its “harmonized” definition, metabolic syndrome (MetS) is described as a
cluster of metabolic factors that increases the risk of cardiovascular diseases, diabetes (DM)
and associated morbidities such as dementia. More specifically, the combined occurrence
of at least three of the following five risk factors would qualify a person for MetS: hyper-
glycemia, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol levels,
hypertension and abdominal obesity. MetS can be modulated by genetics and epigenetics
factors, fostered by sedentary lifestyle, influenced by the quality of food and sleep and
controlled by gut microbiota. It has been estimated that more than one in three adults in
the United States, and approximately 40% of people over the age of 40, have MetS, making
it a major health hazard of the modern world [1].
From a mechanistic perspective, finely tuned, redox-dependent signal transduction
mechanisms underlie and control metabolic dysregulations. Moreover, low-grade systemic
inflammation is usually associated with such endocellular redox alterations and eventually
leads to a dysfunctional metabolic rewiring [2].
Nutrition is one of the most important modifiable factors affecting human health.
Appropriate dietary patterns have, indeed, been demonstrated to effectively counteract
the immunometabolic alterations leading to MetS development [3]. Along these lines, this
Special Issue has been devoted to gathering novel, relevant and significant contributions
on the redox-dependent biochemical mechanisms underlying MetS, along with nutritional
studies analyzing the impact of diet on this metabolic disorder. New information has been
added to this field by means of 14 articles, with 10 original papers and 4 reviews.
In the first paper, Valenzano et al. have evaluated the effect of a very low-calorie
ketogenic diet (VLCKD) in a population of obese patients. The study drew inspiration
from the current knowledge on the effects of caloric restriction and dietary ketosis on the
reduction of visceral adipose tissue (VAT). By employing an integrated in vivo and ex vivo
experimental approach, the authors demonstrated that VLCKD was able to decrease VAT,
ameliorating adiposity and blood chemistry parameters. Moreover, the short-term mild
dietary ketosis did not appear to have a cytotoxic effect, nor was it a condition able to
increase oxidative stress. Relevantly, the study also demonstrated for the first time an effect
of the VLCKD upon the orexinergic system. As a whole, these data further support the
usefulness of such a therapeutic dietary intervention to promote obesity reduction via
hypothalamic mechanisms [4].
In the light of the strict interconnections between the Mediterranean diet, epigenetics
and inflammation, Bordoni et al. investigated the nutrigenomic properties of two high-
quality oils, extra virgin olive (EVO) oil and that of Nigella sativa (NG), in an in vitro model
of low-grade inflammation in human macrophages. The authors demonstrated that both
EVO and NG oil reduced low-grade inflammation through antioxidant and epigenetic
mechanisms. Indeed, both oils were able to restore normal expression levels of DNMT3A
and HDAC1 (but not DNMT3B), which were altered under inflammatory conditions.
Moreover, EVO oil was able to prevent the increase in TET2 expression and reduce global
DNA methylation that were measured in inflamed cells. Interestingly, NG oil seemed to be
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more efficient in the control of proinflammatory cytokines, whereas EVO oil better helped
to counteract redox imbalance [5].
It is now well established that dietary interventions can exert positive effects on MetS
and also induce alterations of gut microbiota. Along these lines, Guirro et al. have assessed
the effects of the citrus polyphenol hesperidin in an in vivo model of MetS with the aim to
elucidate the host–microbiome interplay with extensive anthropometric and biochemical
characterizations. Interestingly, the authors demonstrated that hesperidin supplementation
ameliorated the plasma lipid profile, as well as blood pressure, insulin sensitivity and
relevant markers of arterial stiffness and inflammation. Coherently, metabolomics also
revealed an improvement of the lipidomic profile, a decrease in circulating amino acids
and a lower excretion of inflammation- and oxidative stress-related metabolites. Relevantly,
animals excreted larger amounts of microbial-derived metabolites, which positively corre-
lated with the Bacteroidaceae family. As a whole, these data do support the hypothesis for
a potential use of hesperidin as a prebiotic in the combo therapy of MetS [6].
Besides the beneficial effects of dietary patterns to prevent and/or counteract MetS
development, supplementation with plant-origin extracts has been widely explored over
the last decade. Within this remit of intense research, the study from de la Fuente-Fernandez
et al. has analyzed the protective effects of a carob fruit extract (CSAT+®) on the car-
diometabolic alterations associated with MetS in mice. The authors discovered that CSAT+®
supplementation was able to ameliorate both the glucidic and lipidic plasma profile, sig-
nificantly reducing peripheral insulin resistance (IR), inflammation and oxidative stress.
Moreover, CSAT+® treatment also prevented MetS-induced hypertension, improved vascu-
lar response and attenuated endothelial dysfunction (ED). Finally, cardiomyocyte apoptosis
and an ischemia–reperfusion-induced decrease in cardiac contractility was also prevented
by the fruit extract supplementation [7].
A key issue in the development of MetS is the difference between metabolically healthy
obesity (MHO) and metabolically unhealthy obesity (MUO) phenotypes, partly attributable
to genetic traits that modulate body fat distribution and obesity-related metabolic aspects.
Within this context, no solid reports are available on the genotypic effect of the leptin
receptor (LEPR) gene on fat distribution and obesity-related metabolic abnormalities in
the Korean population. Along these lines, the study by Jang et al. evaluated whether the
difference between MHO and MUO phenotypes might be partly attributable to the LEPR
rs8179183 polymorphism in obese Korean females. Interestingly, the results of the work
revealed that LEPR rs8179183 was associated with metabolic health status in a Korean
population with obesity. Moreover, the paper reported on MUO individuals with the GG
genotype having the most unfavorable values of glucose-related markers, lipid profiles,
adipokines, oxidative stress markers and regional fat distribution [8].
Epidemiological data clearly show that, within dietary patterns and lifestyles, sugar-
sweetened beverages (SSBs) are deeply implicated in MetS development. In light of scanty
mechanistic insights underlying this process, Benade et al. have established a unique rat
model of long-term SSB consumption to deeply analyze the link between SSB consumption
and the onset of type 2 diabetes mellitus (T2DM). Interestingly, the authors showed that
SSB consumption increased hepatic ER stress and altered hepatic mitochondrial dynamics,
antioxidant response and calcium handling across mitochondria-associated ER membranes.
Relevantly, the authors underlined that at this relatively early stage of SSB intake, the
liver could be able to initiate adaptive responses to significantly counteract such stressors.
However, the observed increased mitochondrial fission and decreased fusion could represent
a possible mechanism responsible for the development of MetS and T2DM in the longer
term [9].
Nitric oxide (NO) is widely reported to play a pivotal role in cardiovascular and
metabolic regulations. Coherently, nitrite, a precursor of the NO reservoir abundant in
green leafy vegetables, has been proposed to exert protective effects against T2DM and
cardiovascular diseases. On the other hand, while the role of iNOS as a pro-inflammatory
agent is well established, its protective role under normal physiological conditions and
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cardiovascular disorders is less well investigated. Along these lines, the work by Aggarwal
et al. investigated the incidence of IR in chow-fed iNOS−/− mice and the effect of nitrite
supplementation on the rescue of systemic, hepatic and adipose tissue insulin sensitivity. In-
terestingly enough, the authors demonstrated that chow-fed adult iNOS−/− mice exhibited
systemic IR, dyslipidemia and metabolic perturbations. Relevantly, nitrite supplementation
significantly counteracted IR and glucose tolerance and reduced lipid accumulation by im-
proving hepatic insulin sensitivity and glucose and lipid homeostasis. While demonstrating
that nitrite supplementation improves insulin sensitivity and metabolic homeostasis, the
authors further highlight the metabolic role of iNOS [10].
It has been demonstrated that NO, together with glutathione (GSH), is involved in the
modulation of the hepatic regulation of glucose metabolism. Taking into account the incom-
plete current knowledge of the metabolic action of GSH and NO in glucose homeostasis,
the study from Sousa-Lima et al. was designed to evaluate whether treatment with S-
nitrosoglutathione (GSNO) could revert high-sucrose diet-induced IR in vivo. Interestingly,
GSNO administration was able to revert IR induced by sucrose feeding in a dose-dependent
manner, demonstrating an insulin-sensitizing effect in vivo. From a mechanistic perspective,
these effects were associated with an increased expression of both insulin receptors and
p-Akt in muscle cells after GSNO treatment. In line with this, the authors suggested that
GSNO may act as a potential pharmacological tool for the treatment of IR in obesity and
T2DM [11].
T2DM-induced hyperglycemia has been demonstrated to lead to oxidative stress-
mediated fibrosis in different tissues and organs. The endothelial-to-mesenchymal tran-
sition (EndMT) has been proposed to play a role in T2DM-associated fibrotic conditions.
Along these lines, Giordo et al. have investigated whether EndMT is implicated in the
diabetic retinopathy fibrotic process and evaluated if resveratrol could counteract EndMT
in vitro. Interestingly, the authors discovered that the treatment of primary human retinal
endothelial cells (HRECs) with high glucose (HG) resulted in an increase in intracellular
ROS levels and fostered phenotype shifting towards EndMT. The mechanism appeared to
be mediated by a PKC involvement leading to NADPH-associated ROS generation. Interest-
ingly, resveratrol was able to counteract EndMT via a downregulation of NADPH oxidase,
suggesting a resveratrol-based potential protective therapy to prevent diabetic-associated
complications [12].
Childhood obesity and its metabolic complications have been related to deficient antiox-
idant capacity and oxidative stress. Erythrocytes (RBCs) are constantly exposed to oxidative
stress and hence are provided with powerful antioxidant systems strongly depending on the
pentose phosphate pathway (PPP). Along these lines, in their work, Gonzalez-Dominguez
et al. aimed to assess the efficacy of the PPP (through its NADP dehydrogenases) to provide
reducing power in the RBCs of obese children with IR as compared to a group of metaboli-
cally healthy obese participants and a group of healthy controls. Interestingly, the authors
demonstrated that obese children with IR present higher levels of oxidative damage, blunted
capacity to generate reducing power and hampered function of key NADPH-dependent
antioxidant enzymes. This condition resulted in a deficient response to a glucose overload
as compared with the other study groups. Interestingly enough, the authors found a physio-
logical deviation of redox balance (oxidative eustress) in obese children without IR and a
supraphysiological deviation (oxidative distress) in the IR group [13].
It has widely been recognized how IR and T2DM can play a key role in the etiopatho-
genesis of neurodegenerative pathologies. Additonally, an increasing number of nutraceuti-
cals have been evaluated for their potential to exert protective effects in this regard. Within
this remit of research, Amato et al. reviewed experimental data on the ability of curcumi-
noids, silymarin, chlorogenic acid and Aphanizomenon flos-aquae-derived compounds
to exert beneficial effects on neurodegeneration and in particular in Alzheimer’s disease
models [14].
Hypomagnesemia is commonly observed in both cardiovascular diseases and several
risk factors associated with MetS, such as T2DM and hypertension. Interestingly, low serum
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magnesium (Mg) has been proposed as a predictor for cardiovascular and all-cause mortality.
In their review, Liu et al. reported on the possible mechanisms by which Mg deficiency could
play detrimental roles in cardiovascular diseases and reviewed the results of clinical trials of
Mg supplementation for heart failure, arrhythmias and other cardiovascular diseases [15].
Eryptosis is a coordinated, programmed cell death culminating in the disposal of
cells without disruption of the cell membrane and the release of endocellular oxidative
and pro-inflammatory milieu. While providing a convenient form of death for RBCs,
dysregulated eryptosis may result in a series of detrimental and harmful pathological
consequences. In light of the crucial role played by the eryptotic process in MetS-related
endothelial dysfunction (ED), Restivo et al. reviewed the molecular mechanisms leading
to eryptosis in MetS-related conditions (hyperglycemia, dyslipidemia, hypertension and
obesity). Moreover, the authors also reported the clinical evidence supporting or proposing
a role for eryptosis in ED associated with MetS cardiovascular complications [16].
MetS and non-alcoholic fatty liver disease (NAFLD) are two different entities sharing
common clinical and physio-pathological features, with IR being the most relevant. In
the last review, Rinaldi et al. reported on the “bad company” constituted by MS and
NAFLD and discussed both the mechanistic aspects and the clinical impact related to these
pathological conditions [17].
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